Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
Contacts
Capabilities
Suggested News & Insights
New Guidance on U.S. Procurement Raises Risk to Federal Contractors From Potentially Discriminatory PracticesMay 1, 2026DOJ and DEA Loosen Medical Marijuana Restrictions and Move Toward Broader ReschedulingApril 30, 2026DOJ Announces FOCUS Initiative to Work with Data Miners Filing Qui TamsApril 30, 2026New Guidance on U.S. Procurement Raises Risk to Federal Contractors From Potentially Discriminatory PracticesApril 29, 2026April Antitrust and Competition Bulletin: Top-of-Mind Global Antitrust IssuesApril 27, 2026Seventh Circuit Orders Release of Sidley ClientApril 24, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory